Qualigen Therapeutics, Inc. Common Stock

Go to Qualigen Therapeutics, Inc. Common Stock Website

$2.05

-0.02 (-0.97%)
Live
Previous Close

$2.07

Day Range

$0 - $0

Previous Day Range

$2.02 - $2.13

Market Cap

$3.5 million USD

Day Vol.

0

Previous Day Vol.

73887

Currency

USD

Primary Exchange

Nasdaq

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical th...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Univest Securities, LLC announced the successful closing of a $5.1 million private placement for Qualigen Therapeutics, Inc., a life science company focused on developing cancer treatments.

Related tickers: QLGN.

Read Full Article

Qualigen Therapeutics, Inc. announced the pricing of a public offering of 14,724,058 shares of common stock and pre-funded warrants to purchase up to 11,972,754 shares. The gross proceeds from the offering were approximately $3.46 million, which the company plans to use for operations, clinical trials, and other corporate purposes.

Related tickers: QLGN.

Read Full Article
Trending Tickers

Please sign in to view